AIDS Drugs, HAART Therapies
Immune therapies are treatments which influence or modify certain components of the immune system. besides drugs a number of therapies are being looked into for use by people with HIV by boosting the body’s immunity.
How AIDS Medications are combined and the order in which they are given are important factors to consider when designing treatment strategies for patients new to antiretroviral therapy, says a new study funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. When HIV-infected individuals begin treatment with a combination of the drugs zidovudine, better known as AZT, lamivudine and efavirenz, the drugs retain their effectiveness for a longer period of time than when individuals begin treatment with one of several other three-drug regimens. Highly active antiretroviral therapy (HAART) employs combinations of anti-HIV drugs to help suppress the virus in people with HIV/AIDS. The purpose of HAARt is combined various HIV medications to supress HIV in a multitude of ways. Two classes that help prevent the virus from copying, called RT reverse transcriptase inhibitors RT, PI’s stop the virus from being infectious. RT inhibitors can be further broken down into nucleoside RT inhibitors, which halt HIV replication by making faulty DNA building blocks, and non-nucleoside inhibitors, which bind to the enzyme reverse transcriptase to prevent the virus from copying itself. The effectiveness of different drug combinations may diminish over time, however, and physicians often must implement new ones over the course of a person’s treatment. Combination AIDS HIV regimens are our currently most effective method in the fight against HIV/AIDS. Using this regimens we have been able to prolong lives, improve quality of life and even slow the transmission of HIV/AIDS.